Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;51(2):61-66.

Predictors of Oxygenator Exchange in Patients Receiving Extracorporeal Membrane Oxygenation

Affiliations

Predictors of Oxygenator Exchange in Patients Receiving Extracorporeal Membrane Oxygenation

Robyn Basken et al. J Extra Corpor Technol. 2019 Jun.

Abstract

Thrombosis within the membrane oxygenator (MO) during extracorporeal membrane oxygenation (ECMO) can lead to sudden oxygenator dysfunction with deleterious effects to the patient. The purpose of this study was to identify predictors of circuit exchange during ECMO. This is a single-center, retrospective study of all patients who received ECMO at our institution from January 2010 to December 2015. Changes in potential markers were compared on Day 3 vs. Day 0 before MO exchange. Of the 150 patients who received ECMO, there were 58 MO exchanges in 35 patients. Mean ECMO duration was 21.1 (±12.7) days. D-dimer (DD) (μg/mL) (mean difference -2.6; 95% confidence interval [CI]: -4.2 to -1.1; p = .001) increased significantly in the 3 days leading up to MO exchange, whereas fibrinogen (mg/dL) (mean difference 90.7; 95% CI: 41.8-139.6; p = .001), platelet (PLT) count (1,000/μL) (mean difference 23.3; 95% CI: 10.2-36.4; p = .001), and heparin dose (units/h) (mean difference 261.7; 95% CI: 46.3-477.1; p = .02) decreased. Increasing DD or decreasing fibrinogen, PLT count, or heparin dose may indicate an impending need for MO exchange in patients receiving ECMO. Early identification of these changes may help prevent sudden MO dysfunction.

Keywords: ECMO; oxygenator exchange.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Stratification of patients based on inclusion criteria. Each circuit change is treated as a separate event.

References

    1. Oliver WC. Anticoagulation and coagulation management for ECMO. Semin CardioThorac Vasc Anesth. 2009;13:154–75. - PubMed
    1. Esper SA, Levy JH, Waters JH, et al. . Extracorporeal membrane oxygenation in the adult: A review of anticoagulation and transfusion. Anesth Analg. 2014;118:731–43. - PubMed
    1. Lubnow M, Philipp A, Dornia C, et al. . D-dimers as an early marker for oxygenator exchange in extracorporeal membrane oxygenation. J Crit Care. 2014;29:473.e1–e5. - PubMed
    1. Irby K, Swearingen C, Byrnes J, et al. . Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: A retrospective pediatric study. Pediatr Crit Care Med. 2014;15:e175–812. - PMC - PubMed
    1. Sulkowski JP, Preston TJ, Cooper JN, et al. . Comparison of routine laboratory measures of heparin anticoagulation for neonates on extracorporeal membrane oxygenation. J Extra Corpor Technol. 2014;46:69–76. - PMC - PubMed

LinkOut - more resources